A company commercializing the first new gas sterilization process in over 30 years. Enabling technology for biotechnology products, drug-device combination products and medical devices. I am responsible for all company revenue generation and customer projects. Oversee Sales, Microbiology Lab, Marketing, and Business Development.• Driven annual revenue increases over last 6 years: 2017-2018 +460%, 2018-2019 +24%, 2019-2020 +54%, 2020-2021 +7.5%, and 2021-2022 +61%.• Established and expanded Key Account Program of pharmaceutical and biotech customers by 50% in 2023 over 2022 to drive revenue growth. • Responsibilities include: Sales, Microbiology Lab, Marketing, and Business Development. Four direct reports with an overall team of nine professionals.• Developed and implemented market-based pricing strategy leading to increased revenue in 2022 and 2023.• Led the development of Noxilizer’s new website in 2022 resulting in an increase in new business inquiries, introductory calls and revenue-generating projects.• Personally raised $1.78M in 2008-2009 from angel and institutional investors to fund research and development activities. 70% made additional investments.

Responsible for US marketing, representing 74% of company revenue. Synagis is the only product approved to prevent Respiratory Syncytial Virus (RSV) in premature infants. Responsibilities included: Phase IV strategy, publications, medical education, thought leaders, sales force messaging and promotional tools, public relations strategy, advocacy strategy and direct-to-consumer programs.

Responsible for the global marketing plan for new product in development. Completed business case to move forward to Phase 3. Positive product decision made, resulting in a $450 million clinical plan investment.

Led cross-functional teams responsible for developing the business case for senior management on in-licensing opportunities. Led the development of the draft launch label and lifecycle plan for Amylin’s product, Byetta. Served as a key member of the deal team that successfully negotiated the co-promotion agreement.

District Sales Manager leading a team of ten Sales Representatives. Successfully turned around a low performing district in 12 months.

Led a team of three Marketing Associates. Successfully launched Lilly’s first insulin pen in the US market. Developed the marketing plan and budget as part of the deal team that successfully negotiated the co-promotion agreement for Actos with Takeda. Implemented the first direct-to-consumer campaign at the company in support of the Humalog launch.